Jefferson University Hospitals

Ewing Sarcoma

Ewing sarcoma is the second most common malignant bone tumor in children and adolescents. As with any cancer, a multidisciplinary team of specialists is required for treatment and the best prognosis. At Jefferson, our multidisciplinary team of orthopedic surgeons, radiologists, pathologists, medical oncologists and radiation oncologists can offer expert diagnosis and treatment of Ewing sarcoma.

The Jefferson Musculoskeletal Oncology Center in Philadelphia provides complete treatment for several hundred patients a year with complex musculoskeletal oncologic problems, many with relatively rare bone and soft tissue sarcomas.

Additionally, the Kimmel Cancer Center at Jefferson is recognized as a National Cancer Institute (NCI)-designated Cancer Center in the nation.

Advantages of Ewing Sarcoma Treatment at Jefferson

At the Musculoskeletal Oncology Center, sarcoma experts meet on a regular basis to review all new patients' conditions. This team includes radiologists, pathologists, radiation oncologists, medical oncologists and orthopedic surgeons, who come together to decide on the best course of treatment for each patient.

Our services include:

  • Complete orthopedic oncology specific management of sarcoma, benign lesions of bone and soft tissue, metastatic disease to skeleton and extremities
  • Routine orthopedic surgery in oncology patients
  • Management of orthopedic complications of oncology treatment
  • Evaluation and treatment of spinal tumors

Recurrence among Jefferson patients is low, thanks to not only the quality of orthopedic oncology surgery, radiation therapy and medical oncology, but also diligent routine monitoring.